Kutzner J, Kremer H B
Strahlentherapie. 1985 Mar;161(3):127-30.
From 1963 to 1978 119 patients with a carcinoma of the tonsillar fossa received cobalt-60-therapy from 60 to 70 Gy to the primary lesion and the lymph nodes. The 5-year-survival-rate was 34%, with a combined therapy of surgery and irradiation it was 43.6%. For 44 patients with a sarcoma of the tonsillar fossa the 5-year-survival was 32%. For the patients with a carcinoma chemotherapy was only given for palliation.
1963年至1978年期间，119例扁桃体窝癌患者接受了钴-60治疗，原发灶和淋巴结的照射剂量为60至70 Gy。5年生存率为34%，手术和放疗联合治疗时为43.6%。44例扁桃体窝肉瘤患者的5年生存率为32%。对于癌患者，化疗仅用于姑息治疗。
